M&A Deal Summary |
|
|---|---|
| Date | 2023-09-06 |
| Target | Tramontane |
| Sector | Life Science |
| Buyer(s) | Kriya Therapeutics |
| Deal Type | Add-on Acquisition |
SEARCH BY
Kriya Therapeutics is a fully integrated company provides novel technologies and therapeutics in gene therapy. Kriya is organized into four principal business units: Kriya Technologies™, Kriya Therapeutics™, Kriya R&D™, and Kriya Manufacturing™. Kriya Therapeutics is based in Redwood City, California.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Spain M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-07 |
Warden Bio
United States Warden Bio is a company developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). Warden Bio is based in United States. |
Buy | - |